Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah S Kawasaki

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 27, 2022
Disability-Adjusted Life-Years for Drug Overdose Crisis and COVID-19 Are Comparable During the Two Years of Pandemic in the United StatesQiushi Chen, Paul M Griffin, Sarah S Kawasaki
Journal of Substance Use and Addiction Treatment|September 20, 2023
COVID-19-related flexibility in methadone take-home doses associated with decreased attrition: Report from an opioid treatment program in central PennsylvaniaSarah S Kawasaki, Rachel Zimmerman, Chan Shen, et al.
Substance Use : Research and Treatment|March 4, 2024
Opioid Overdose Hospitalizations During COVID-19: The Experience of PennsylvaniaChan Shen, James Douglas Thornton, Ning Li, et al.
Journal of Addiction Medicine|November 7, 2023
ASAM Clinical Considerations: Buprenorphine Treatment of Opioid Use Disorder for Individuals Using High-potency Synthetic OpioidsMelissa B Weimer, Andrew A Herring, Sarah S Kawasaki, et al.
JAMA Network Open|January 6, 2026
Barriers to Buprenorphine Initiation in Patients Using FentanylSarah S Kawasaki, Jane M Liebschutz, Cristina Murray-Krezan, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|September 11, 2016
Combination Extended Smoking Cessation Treatment Plus Home Visits for Smokers With Schizophrenia: A Randomized Controlled TrialArthur L Brody, Todd Zorick, Robert Hubert, et al.
Journal of Substance Use and Addiction Treatment|April 26, 2026
"Smart" harm reduction vending machines to improve public health: Evaluating the utilizationAlice Zhang, Jennifer Murphy, Paul M Griffin, et al.
Substance Abuse|October 4, 2021
Research priorities for expanding access to methadone treatment for opioid use disorder in the United States: A National Institute on Drug Abuse Center for Clinical Trials Network Task Force reportPaul J Joudrey, Gavin Bart, Robert K Brooner, et al.
Journal of General Internal Medicine|June 2, 2025
Understanding the characteristics and comorbidities of primary care patients with risky opioid use: Baseline data from the multi-site "Subthreshold Opioid Use Disorder Prevention" (STOP) TrialYasna Rostam-Abadi, Jane M Liebschutz, Geetha Subramaniam, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 27, 2022
Disability-Adjusted Life-Years for Drug Overdose Crisis and COVID-19 Are Comparable During the Two Years of Pandemic in the United StatesQiushi Chen, Paul M Griffin, Sarah S Kawasaki
Journal of Substance Use and Addiction Treatment|September 20, 2023
COVID-19-related flexibility in methadone take-home doses associated with decreased attrition: Report from an opioid treatment program in central PennsylvaniaSarah S Kawasaki, Rachel Zimmerman, Chan Shen, et al.
Substance Use : Research and Treatment|March 4, 2024
Opioid Overdose Hospitalizations During COVID-19: The Experience of PennsylvaniaChan Shen, James Douglas Thornton, Ning Li, et al.
Journal of Addiction Medicine|November 7, 2023
ASAM Clinical Considerations: Buprenorphine Treatment of Opioid Use Disorder for Individuals Using High-potency Synthetic OpioidsMelissa B Weimer, Andrew A Herring, Sarah S Kawasaki, et al.
JAMA Network Open|January 6, 2026
Barriers to Buprenorphine Initiation in Patients Using FentanylSarah S Kawasaki, Jane M Liebschutz, Cristina Murray-Krezan, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|September 11, 2016
Combination Extended Smoking Cessation Treatment Plus Home Visits for Smokers With Schizophrenia: A Randomized Controlled TrialArthur L Brody, Todd Zorick, Robert Hubert, et al.
Journal of Substance Use and Addiction Treatment|April 26, 2026
"Smart" harm reduction vending machines to improve public health: Evaluating the utilizationAlice Zhang, Jennifer Murphy, Paul M Griffin, et al.
Substance Abuse|October 4, 2021
Research priorities for expanding access to methadone treatment for opioid use disorder in the United States: A National Institute on Drug Abuse Center for Clinical Trials Network Task Force reportPaul J Joudrey, Gavin Bart, Robert K Brooner, et al.
Journal of General Internal Medicine|June 2, 2025
Understanding the characteristics and comorbidities of primary care patients with risky opioid use: Baseline data from the multi-site "Subthreshold Opioid Use Disorder Prevention" (STOP) TrialYasna Rostam-Abadi, Jane M Liebschutz, Geetha Subramaniam, et al.
Pageof 1